It was previously observed that the expression levels of inflammatory factors, such as IL-1β and IL-18 were increased in the serum of epilepsy patients during the interseizure period and that the levels of IL-17A and IFN-γ in the plasma of epileptic patients with different seizure types reflected the severity of epilepsy (16–18). The gene discussed is IL17A; the disease is epilepsy.